Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-07-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Stock Option (Right to Buy) −100 9,541
2019-06-30 Christmas Patrick J. SVP, General Counsel Grant or award +52 $36.83 $2K 3,058
2019-06-19 Mills Kenneth T. President and CEO Exercise or conversion +15,000 $0.85 $13K 261,000
2019-06-19 Mills Kenneth T. President and CEO Sale −10,880 $52.27 $569K 250,120
2019-06-19 Mills Kenneth T. President and CEO Sale −4,120 $53.25 $219K 246,000
2019-06-19 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −15,000 114,670
2019-06-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion +5,000 $12.10 $61K 8,006
2019-06-18 Christmas Patrick J. SVP, General Counsel Sale −2,966 $52.74 $156K 5,040
2019-06-18 Christmas Patrick J. SVP, General Counsel Sale −1,934 $53.29 $103K 3,106
2019-06-18 Christmas Patrick J. SVP, General Counsel Sale −100 $54.75 $5K 3,006
2019-06-18 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −5,000 44,931
2019-05-31 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 Glucksmann Alexandra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-31 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-28 Simpson Curran SVP, Product Development & CTO Exercise or conversion +18,000 $22.00 $396K 57,500

Page 27 of 43 · 852 trades